

Dec 12, 2003
Single versus double autologous stem-cell transplantation for multiple myeloma
IFM - Time Frame: October 1994 and March 1997 IFM (Intergroupe Francophone du Myelome) N Engl J Med, 2003 Dec 25 Single versus double...
106


Dec 11, 2003
NCT00056160 : Phase 3 - CC-5013 (lenalidomide) Dex Vs Dex Alone Previously Treated Multiple Myeloma
Multiple Myeloma (009) MM-009 NCT00056160 : Phase 3 - CC-5013 Plus Dex Versus Dex Alone in Previously Treated Subjects With Multiple...
149


Dec 10, 2003
FDA Approved for Multiple Myeloma treatment: Bortezomib (formerly PS-341)
On May 13, 2003, the U.S. Food and Drug Administration (FDA) granted accelerated approval for bortezomib (formerly PS-341), Velcade....
136